Want to see PRVA full AI Analyst Report?
PRVA Stock Chart & Stats
$25.50
-$0.34(-1.35%)
At close: 4:00 PM EDT
$25.50
-$0.34(-1.35%)
Day’s Range― - ―
52-Week Range$19.53 - $28.82
Previous CloseN/A
Volume332.47K
Average Volume (3M)1.22M
Market Cap
$2.87B
Enterprise Value$3.04K
Total Cash (Recent Filing)$412.20B
Total Debt (Recent Filing)$8.73B
Price to Earnings (P/E)99.5
Beta0.76
Next Earnings
Nov 05, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding127,734,210
10 Day Avg. Volume1,248,843
30 Day Avg. Volume1,218,545
Financial Highlights & Ratios
PEG Ratio2.14
Price to Book (P/B)3.93
Price to Sales (P/S)1.36
P/FCF Ratio17.86
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$31.67Price Target Upside24.18% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)0.26
Revenue Forecast (FY)$2.45B
Bulls Say, Bears Say
Bulls Say
Network Scale & Provider GrowthA growing provider base and high retention establish durable scale advantages: larger patient panels and sticky partnerships boost recurring practice‑management fees, strengthen payer negotiation leverage, and create network effects that support cross‑selling technology and value‑based contracts over multiple quarters.
Value‑based Attributed Lives GrowthRapid expansion of attributed lives signals deeper penetration into value‑based care, increasing the population eligible for shared savings and quality incentives. This scale in risk arrangements enhances recurring incentive revenue potential and strengthens long‑term differentiation versus fee‑for‑service peers.
Strong Liquidity And Margin ProgressA cash‑rich, debt‑free position coupled with improving adjusted EBITDA and management's high EBITDA‑to‑FCF conversion target provides durable financial flexibility to fund tuck‑in M&A, AI investments, and platform scaling without near‑term refinancing risk.
Bears Say
TTM Negative Operating & Free Cash FlowThe reported TTM cash‑flow reversal is a material structural concern: a large negative operating and free cash flow figure either reflects a severe cash drain or a reporting anomaly. Either way it elevates funding and execution risk and may force capital conservation or external financing until clarified.
Thin Profitability And Low MarginsDespite revenue growth, very low net and EBITDA margins leave limited buffer against cost inflation, payer rate pressure, or integration costs. Structural margin thinness constrains reinvestment and makes earnings and cash conversion sensitive to modest operational or reimbursement setbacks.
Payer/regulatory Timing & Variability RiskCMS settlement timing, new cash‑tax obligations, and ongoing MA/Medicaid plan shifts create persistent, state‑level variability in revenue and cash receipts. These structural external risks can materially distort year‑end cash conversion and complicate near‑term forecasting and provider payout timing.
PRVA FAQ
What was Privia Health Group, Inc.’s price range in the past 12 months?
Privia Health Group, Inc. lowest stock price was $19.53 and its highest was $28.82 in the past 12 months.
What is Privia Health Group, Inc.’s market cap?
Privia Health Group, Inc.’s market cap is $2.87B.
When is Privia Health Group, Inc.’s upcoming earnings report date?
Privia Health Group, Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 86 days.
How were Privia Health Group, Inc.’s earnings last quarter?
Privia Health Group, Inc. released its earnings results on Aug 06, 2026. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.067 by $0.003.
Is Privia Health Group, Inc. overvalued?
According to Wall Street analysts Privia Health Group, Inc.’s price is currently Undervalued.
Does Privia Health Group, Inc. pay dividends?
Privia Health Group, Inc. does not currently pay dividends.
What is Privia Health Group, Inc.’s EPS estimate?
Privia Health Group, Inc.’s EPS estimate is 0.09.
How many shares outstanding does Privia Health Group, Inc. have?
Privia Health Group, Inc. has 127,734,210 shares outstanding.
What happened to Privia Health Group, Inc.’s price movement after its last earnings report?
Privia Health Group, Inc. reported an EPS of $0.07 in its last earnings report, beating expectations of $0.067. Following the earnings report the stock price went down -8.18%.
Which hedge fund is a major shareholder of Privia Health Group, Inc.?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.67 (24.18% Upside)
$31.67 (24.18% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 327.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $76.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 8.0%
Last 30 Days ▼ 8.0%
News Sentiment
Very Bullish
Bullish news 87%
Bearish news 13%
Bearish news 13%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.44%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
19.80%
Trailing 12-Months
Company Description
Privia Health Group, Inc.
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
PRVA Company Deck
PRVA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong set of operational and financial results — double-digit growth in implemented providers, attributed lives and practice collections, substantial adjusted EBITDA growth and notable margin expansion — supported by a cash-rich, no-debt balance sheet and continued M&A and market expansion. The primary risks discussed were timing-related (possible CMS shared-savings settlement delay and cash-tax timing), a Q2 observation that provider payments grew faster than revenue, and near-term market/payer variability. Management maintained conservative guidance posture for the back half of the year despite raising full-year outlook ranges for several metrics and emphasized AI and scale levers to continue margin improvement.View all PRVA earnings summariesPRVA Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$31.67
▲(24.18% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
0.86% Insiders
27.94% Mutual Funds
5.08% Other Institutional Investors
41.74% Public Companies and
Individual Investors











